Perspectum Lands Top Spot in Alantra Pharma Fast 50 Rankings. Read more
A Closer Look at Fatty Liver Disease and NASH
Date: 24 September 2020
Time: 3 PM PST | 5 PM CST | 11 PM BST
Did you know millions of people across the world are affected by a silent disease that is damaging their internal organs and often goes undetected until it is too late?
That’s why we’ve created LiverMultiScan®, an MRI-based assessment of liver tissue, to revolutionize the NASH clinical pathway and combat the rising burden of NAFLD / NASH.
In this webinar, we will discuss what challenges doctors face when identifying, treating and monitoring fatty liver disease, what role non-invasive patient-friendly tests play, and what support is available for patients suffering from fatty liver disease.
- The current challenges of NASH in clinical practice
- Integrating LiverMultiScan into the diagnostic pathway for NASH patients
- The importance of patient groups for support and recovery
Professor Carlos Duncker
Medical Science Liaison at Perspectum
Carlos started his career as an MD and completed residency programs in Internal Medicine and Nuclear Medicine as well as a PhD in Medicine and Surgery. Carlos was previously the head of the Nuclear Medicine and Molecular Imaging Department at the Children’s Hospital of Mexico, was Medical Advisor to the National Commission of Nuclear Safety and Safeguards and was Professor of Medical Physics at Autonomous National University of Mexico for several years. He has published 176 medical papers and was a Reviewer for the European Journal of Nuclear Medicine and Molecular Imaging under two Editors for more than a decade. He is a Distinguished Fellow of the American College of Nuclear Medicine and a Senior Member of the Mexican Academy of Surgery. Before joining Perspectum, Carlos managed the hepatology research at the Texas Digestive Disease Consultants (TDDC, the largest GI medical private practice in the USA). During his time at TDDC, Carlos positioned the hepatology research site as a top enroller for NASH clinical trials with the lowest screen failure rate among all US sites for multiple trials.
Christina S. Strahotin, MD
Transplant Hepatologist and Gastroenterologist for the Allegheny Health Network and Board Member at NASH Knowledge
A triple board certified in Internal Medicine, Gastroenterology and Transplant Hepatology. Dr. Strahotin is currently a Transplant Hepatologist and Gastroenterologist for the Allegheny Health Network. She works closely with all specialists and services including liver transplant surgeons, critical care physicians, case managers and social works to provide exceptional patient care.
Vice President and Board Member at NASH Knowledge
Betsy Villiotti is a member of the Board and is heavily involved in the daily activities of NASH kNOWledge. She is the organizer and administrator for our NASH/Liver Transplant Support Group. Villiotti brings the important caregiver perspective, as she quickly became Tony’s caregiver during his journey. She is a retired school teacher who still occasionally substitutes in the Chartiers Valley School District. Villiotti also volunteers for the Center for Organ Recovery & Education (CORE). She is a graduate of Slippery Rock University.